University Hospital Motol
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Marel, Miloslav
LUCAS, NCT04228237: LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients

Recruiting
N/A
2300
RoW
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s., OAKS Consulting s.r.o.
Lung Cancer
05/25
05/25
Center, Call
NCT06487364: Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

Recruiting
N/A
39
RoW
Rehabilitation
Emre Şenocak
Parkinson Disease
01/25
01/25
NCT06482502: Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients

Recruiting
N/A
34
RoW
Emre Şenocak
Parkinson Disease
12/24
12/24
NCT06580171: Validation of Walking and Remembering Test

Recruiting
N/A
30
RoW
Walking and Remembering Test
Emre Şenocak
Healthy Individuals
01/25
01/25
Sediva, Anna
NCT05755035: A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Recruiting
2/3
75
Europe, US, RoW
TAK-881, Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (rHuPH20)., HYQVIA, Immune Globulin Infusion (Human), 10% Solution with rHuPH20.
Takeda, Takeda Development Center Americas, Inc.
Primary Immunodeficiency Diseases (PID)
02/26
09/26

Download Options